Results 261 to 270 of about 93,749 (369)

Prevalence of Metabolic‐Associated Steatotic Liver Disease in Patients With Primary Aldosteronism

open access: yesClinical Endocrinology, EarlyView.
ABSTRACT Objective To assess the prevalence of metabolic associated steatotic liver disease (MASLD) in patients with primary aldosteronism (PA) compared to benign adrenal adenomas, and to evaluate the impact of hormonal excess in inducing MASLD. Design Single‐centre retrospective study. Methods Hepatic steatosis was assessed by liver/spleen (L/S) ratio
Irene Tizianel   +6 more
wiley   +1 more source

Patient Participation in Urine Specific Gravity Screening for Arginine Vasopressin Deficiency in an Inpatient Neurosurgical Clinic

open access: yesClinical Endocrinology, EarlyView.
ABSTRACT Objective Detecting hypotonic urine (specific gravity < 1005 g/L) is crucial for the early identification of arginine vasopressin deficiency (AVP‐deficiency), a common complication after pituitary surgery. This study aimed to evaluate the agreement between urine specific gravity measurements taken by patients using urine test strips and those ...
Jeanne‐Marie Nollen   +7 more
wiley   +1 more source

Workshop 17: Pituitary Tumors [PDF]

open access: bronze, 1994
Ignacio Félix
openalex   +1 more source

Eyes Offshore: Reporting the Eye Health Needs of Refugees and Asylum Seekers in Australia's Offshore Detention Centres

open access: yesClinical &Experimental Ophthalmology, EarlyView.
ABSTRACT Background In the last two decades, over 250 000 refugees and asylum seekers have arrived in Australia, many of whom experience significant health problems. Information about their eye health is scarce, particularly for those detained offshore. This is the first study to explore the eye health and services available to this population, helping
Marcel M. Nejatian   +3 more
wiley   +1 more source

Aggressive Pituitary Tumors and Pituitary Carcinomas: From Pathology to Treatment.

open access: yesJ Clin Endocrinol Metab, 2023
Burman P   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy